Balance Therapeutics Stock

balance-therapeutics.comHealthcare / BioTech & PharmaFounded: 2009Funding to Date: $57.17MM

Balance Therapeutics Inc is a biotechnology company addressing conditions of intellectual disability.

Register To Buy and Sell Shares

For more details on financing and valuation for Balance Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Balance Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Balance Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Lyndon Lien Ph.D
President, Chief Executive Officer and Board Member
Xiao-Xiong Lu Ph.D
Vice President, Technical Operations
Herb Cross
Chief Financial Officer

Board Members

Carl Gordon Ph.D
Michael Grey
Pappas Capital
Ernest Mario Ph.D
Pappas Capital
Richard Chin MD
Lyndon Lien Ph.D
Peter Carlton
Oakmont (Los Angeles)

Frequently Asked Questions About Balance Therapeutics’ Stock

Can you buy Balance Therapeutics’ stock?
Balance Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Balance Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Balance Therapeutics’ stock?
Yes, you can sell stock of a private company like Balance Therapeutics. Forge can help you sell your Balance Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Balance Therapeutics’ stock price?
Balance Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Balance Therapeutics’ private market stock price with Forge Data.
What is Balance Therapeutics’ stock ticker symbol?
Balance Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Baby registry megasite Babylist opening first retail store
Sarepta Therapeutics has a healthy balance sheet, according to an analysis by Simply Wall St. As of September 2023, the company held $1.24bn of debt, down from $1.54bn a year prior, and $1.73bn of cash. While the firm reported revenue of $1.1bn over the past year, up 26%, it did not report any earnings before interest and tax, indicating it is yet to reach profitability. The company's revenue growth suggests it may be in a position to turn a profit in the future.
Updated on: May 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.